Sunshine Biopharma, Inc. (NASDAQ:SBFM) Short Interest Update

Sunshine Biopharma, Inc. (NASDAQ:SBFM) saw a significant drop in short interest in November. As of November 15th, there was short interest totalling 234,100 shares, a drop of 37.4% from the October 31st total of 374,100 shares. Currently, 11.7% of the shares of the stock are short sold. Based on an average trading volume of 612,800 shares, the short-interest ratio is currently 0.4 days.

Sunshine Biopharma Stock Down 10.2 %

NASDAQ SBFM traded down $0.31 on Thursday, reaching $2.73. The company had a trading volume of 552,331 shares, compared to its average volume of 254,545. The firm’s 50 day moving average price is $2.86 and its 200 day moving average price is $1.81. Sunshine Biopharma has a 12 month low of $2.11 and a 12 month high of $608.00. The stock has a market capitalization of $3.33 million, a PE ratio of -0.02 and a beta of 1.38.

Sunshine Biopharma (NASDAQ:SBFM) last posted its earnings results on Tuesday, November 5th. The company reported ($0.94) EPS for the quarter, missing analysts’ consensus estimates of $9.00 by ($9.94). The firm had revenue of $8.44 million during the quarter. Sunshine Biopharma had a negative return on equity of 17.89% and a negative net margin of 12.82%.

About Sunshine Biopharma

Sunshine Biopharma, Inc, a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products.